Ask your healthcare provider about AspyreRx™ today
Available by prescription only
AspyreRx requires a prescription - and it’s not a drug
AspyreRx is the first digital behavioral treatment to receive FDA authorization for adults with type 2 diabetes.
It is backed by clinical data showing reduction in A1c, systolic blood pressure, and weight, while improving mood and quality of life.
Ready to fill your prescription?
The moment your healthcare provider prescribes AspyreRx, you will receive a confirmation email or text message from PhilRx, our online pharmacy partner to start filling your prescription — within minutes.*
*Processing your prescription can vary, depending on insurance requirements.
You will receive a text or email with a confirmation link from ‘PhilRx’, click to confirm your information
‘PhilRx’ will then verify your insurance coverage and any out-of-pocket costs
Follow instructions to finalize your prescription and get started on the app
Getting started with AspyreRx
Your unique treatment arrives
Once your prescription has been filled, PhilRx will send you an activation link through email or SMS with a 6-digit code. Click on that link!
An activation code keeps your prescription safe
Your activation code might be automatically populated or manually entered, so keep that PhilRx SMS with a 6-digit code handy.
Create your AspyreRx account and begin treatment
Follow the app instructions to create your new AspyreRx account that you will use to start treatment. Begin onboarding and off you go.
The more you do, the better your results will be
People who complete more lessons in AspyreRx see greater improvements to their blood sugar
Download the app
While your prescription is being filled, download the app to get a head start. When you receive your unique treatment link with the activation code from PhilRx, you can begin the treatment.
Processing your prescription can vary, depending on insurance requirements.
Have questions?
We’re here to help.
Indications for use:
AspyreRx is a prescription-only digital therapeutic device intended to provide cognitive behavioral therapy to patients 18 years or older with type 2 diabetes. The device targets behavior to aid in the management of type 2 diabetes in patients who are under the care of a healthcare provider. AspyreRx provides cognitive behavioral therapy as a treatment that should be used adjunctively with standard of care.
Notes regarding indications for use:
The device is not intended for use as a stand-alone therapy.
The device is not a substitute for a patient’s prescribed therapy or medication.
The benefit of treatment with the device was not evaluated beyond 180 days of treatment. The ability of the device to prevent potential relapse into prior behaviors after treatment discontinuation has not been studied.
The benefit of the device without the use of study-related compensation for glycemic monitoring has not been evaluated.
The device should not be used by people with unstable psychiatric disorders.
The device should not be used by people with severe psychiatric disorders and is not intended for use as a treatment for any psychiatric disorder or symptom.